Average Co-Inventor Count = 3.57
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Respira Therapeutics, Inc. (11 from 14 patents)
2. Other (2 from 832,966 patents)
3. Abbott Vascular, Inc. (1 from 37 patents)
14 patents:
1. 12364701 - PDE5 inhibitor powder formulations and methods relating thereto
2. 12263174 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders
3. 11911390 - PDE5 inhibitor powder formulations and methods relating thereto
4. 11806314 - PDE5 inhibitor powder formulations and methods relating thereto
5. 11491160 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders
6. 11491161 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders
7. 11471623 - Powder dispersion methods and devices
8. 10912778 - Methods for treatment of pulmonary hypertension
9. 10682476 - Powder inhaler, system and methods
10. 10525216 - Powder dispersion methods and devices
11. 10463815 - Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
12. 9750385 - Handheld scrubbing tool
13. 8932324 - Redundant tissue closure methods and apparatuses
14. 5492621 - Sewage water and solids treatment and disposal system